Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
    1.
    发明申请
    Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality 审中-公开
    使用灌注种子培养提高生物制药饲料分批生产能力和产品质量

    公开(公告)号:US20160289633A1

    公开(公告)日:2016-10-06

    申请号:US15038698

    申请日:2014-12-19

    Applicant: Biogen MA Inc.

    Abstract: Methods of improving the efficiency of production of a protein product of interest in mammalian cell culture are presented. In particular, the methods result in an increase in the quantity of a protein product produced, or decreases protein product production time in a manufacturing-scale bioreactor cell culture. The disclosed methods comprise: (a) culturing the N-1 bioreactor culture to high viable cell densities; and (b) seeding the production bioreactor culture at high viable cell seeding densities.

    Abstract translation: 提出了提高哺乳动物细胞培养中感兴趣的蛋白质产品生产效率的方法。 特别地,所述方法导致产生的蛋白质产物的量的增加,或减少制造规模的生物反应器细胞培养物中的蛋白质产物生产时间。 所公开的方法包括:(a)将N-1生物反应器培养物培养成高活细胞密度; 和(b)将生产生物反应器培养物以高活细胞播种密度接种。

Patent Agency Ranking